Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

New t-PA, u-PA and plasmin inhibitors presented by Alxerion Biotech

April 9, 2020

Catalyst announces pivotal phase III design for MarzAA

April 8, 2020

FDA approves Reblozyl to treat anemia in MDS

April 6, 2020

FDA approves Sevenfact for hemophilia A and B

April 2, 2020

FORMA Therapeutics identifies new pyruvate kinase PKLR activators

April 2, 2020

FDA accepts IND application for OTQ-923

April 2, 2020

FDA approves new intravenous formulation of Triferic

March 30, 2020

Otsuka Pharmaceutical identifies AhR antagonists

March 25, 2020

Desmopressin shows promise for the management of bleeding in rectal cancer

March 20, 2020

Cellphire cleared to begin phase II study of Thrombosomes in bleeding patients with thrombocytopenia

March 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.